title: Role of prefrontal cortical calcium independent phospholipase A₂ in antidepressant-like effect of maprotiline.
abstract: There is increasing interest in the pathophysiology and neurochemistry of the prefrontal cortex (PFC) in depression. Blood flow and metabolism are decreased in the PFC of patients with depression compared to controls. Changes in long-chain polyunsaturated fatty acids (PUFAs) are also associated with depression. This study was conducted to elucidate a possible role of PFC activity of an enzyme involved in the release of docosahexaenoic acid (DHA), i.e. calcium-independent phospholipase A2 (iPLA₂), in the effects of the norepinephrine reuptake inhibitor (NRI) antidepressant, maprotiline, in mice. Treatment of Balb/C mice with maprotiline for 4 wk resulted in reduction in the level of behavioural despair, as determined by decreased immobility and increased climbing during the forced swim test. In contrast, mice treated with maprotiline plus bilateral prefrontal cortical injections of antisense oligonucleotide to iPLA₂, showed significantly increased immobility and decreased climbing, to levels comparable to saline-treated controls, indicating abolishment of the antidepressant-like effect of maprotiline. Lipidomic analyses showed significant decreases in phosphatidylcholine species containing long-chain PUFAs and increases in lysophosphatidylcholine after maprotiline treatment, indicating increased PLA₂ activity and endogenous release of eicosapentaenoic acid (EPA) or DHA after maprotiline treatment. These changes in lipid profiles were absent in mice that received maprotiline and PFC injections of antisense oligonucleotide to iPLA₂. Together, the results indicate that PFC iPLA₂ activity plays an important role in the antidepressant-like effect of maprotiline, possibly through endogenous release of long-chain PUFAs.
authors.affiliation: Department of Pharmacology, National University of Singapore, Singapore.
authors.forename: Lynette Hui-Wen
authors.initials: LH
authors.lastname: Lee
authors.forename: Chay-Hoon
authors.initials: CH
authors.lastname: Tan
authors.forename: Guanghou
authors.initials: G
authors.lastname: Shui
authors.forename: Markus R
authors.initials: MR
authors.lastname: Wenk
authors.forename: Wei-Yi
authors.initials: WY
authors.lastname: Ong
mesh_terms: D000818:Animals; D018687:Antidepressive Agents, Second-Generation; D002118:Calcium / Q000378:metabolism; D016923:Cell Death / Q000187:drug effects; D002851:Chromatography, High Pressure Liquid; D046352:Freezing Reaction, Cataleptic / Q000187:drug effects; D020287:In Situ Nick-End Labeling; D007211:Indoles; D050356:Lipid Metabolism / Q000187:drug effects; D008297:Male; D008376:Maprotiline / Q000494:pharmacology*; D013058:Mass Spectrometry; D051379:Mice; D008807:Mice, Inbred BALB C; D020319:Oligodeoxyribonucleotides, Antisense / Q000494:pharmacology; D054512:Phospholipases A2, Calcium-Independent / Q000378:metabolism*; D017397:Prefrontal Cortex / Q000187:drug effects* / Q000378:metabolism*; D013550:Swimming / Q000523:psychology
chemical_list: D018687:Antidepressive Agents, Second-Generation; D007211:Indoles; D020319:Oligodeoxyribonucleotides, Antisense; D008376:Maprotiline; C007293:DAPI; D054512:Phospholipases A2, Calcium-Independent; D002118:Calcium